CDK12: A Potent Target and Biomarker for Human Cancer Therapy

Shujing Liang1,2,3, Lifang Hu1,2,3, Zixiang Wu1,2,3

  • 1Laboratory for Bone Metabolism, Xi'an Key Laboratory of Special Medicine and Health Engineering, Northwestern Polytechnical University, Xi'an 710072, China.

Cells
|June 24, 2020
PubMed

Insights

Cyclin-dependent kinase 12 (CDK12) regulates crucial cellular functions including transcription and DNA repair. Emerging research highlights CDK12

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Cyclin-dependent kinases (CDKs) are essential serine/threonine protein kinases regulating fundamental cellular processes.
  • Cyclin-dependent kinase 12 (CDK12) is a key transcription-associated CDK involved in diverse cellular functions.

Purpose of the Study:

  • To summarize current knowledge on CDK12's biological functions.
  • To review research advances concerning CDK12's role in human cancers.
  • To highlight CDK12 as a potential cancer biomarker and therapeutic target.

Main Methods:

  • Literature review of existing research on CDK12.
  • Analysis of CDK12's involvement in gene transcription, RNA splicing, and DNA damage response (DDR).
  • Examination of CDK12's implications in cell cycle progression and proliferation.

Main Results:

  • CDK12 plays versatile roles in regulating transcription, RNA processing, and DNA repair.
  • Evidence increasingly implicates CDK12 in the development and progression of various human cancers.
  • CDK12 demonstrates potential as both a diagnostic biomarker and a therapeutic target in oncology.

Conclusions:

  • CDK12 is a critical regulator of essential cellular processes.
  • CDK12's significant role in human cancers positions it as a promising target for novel cancer therapies.
  • Further research into CDK12 functions may unlock new strategies for cancer treatment and diagnosis.

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K